Volume 63, Issue 2, Pages (February 2003)

Slides:



Advertisements
Similar presentations
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages
Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
V.M. Campese, N. Mitra, D. Sandee  Kidney International 
Volume 70, Issue 10, Pages (November 2006)
Plasma sodium and hypertension
Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction 
Viper venom for diabetic nephropathy
The effect of hypertension on the risk for kidney cancer in Korean men
Membranous nephropathy: When and how to treat
Viper venom for diabetic nephropathy
Continuous renal replacement therapy in the critically ill patient
Progression of renal failure and hypertensive nephrosclerosis
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 77, Issue 1, Pages 6-8 (January 2010)
The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis  Florence Wong*, Kenneth Sniderman‡,
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar 
V.M. Campese, N. Mitra, D. Sandee  Kidney International 
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
Comorbidity and confounding in end-stage renal disease
Volume 66, Issue 3, Pages (September 2004)
Steven J. Rosansky, Richard J. Glassock  Kidney International 
Volume 70, Issue 11, Pages (December 2006)
Volume 87, Issue 2, Pages (February 2015)
Volume 60, Issue 1, Pages (July 2001)
Volume 71, Issue 6, Pages (March 2007)
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Volume 70, Issue 12, Pages (December 2006)
Fructose intake as a risk factor for kidney stone disease
Volume 78, Issue 8, Pages (October 2010)
Endothelial dysfunction and inflammation: What is the link?
Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen  David I. Ortiz-Melo, Robert F. Spurney 
The third World Kidney Day: Looking back and thinking forward
Impact of gender on the renal response to angiotensin II
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Angiotensin II production and distribution in the kidney – II
Volume 87, Issue 1, Pages (January 2015)
The kidney, a cardiovascular risk marker, and a new target for therapy
Volume 67, Pages S52-S54 (January 2005)
Volume 63, Issue 2, Pages (February 2003)
Nephrology Crossword: Glomerulonephritis
Volume 71, Issue 4, Pages (February 2007)
Circadian regulation of renal function
Volume 57, Issue 2, Pages (October 2000)
Volume 73, Issue 9, Pages (May 2008)
Volume 73, Issue 3, Pages (February 2008)
Volume 64, Issue 2, Pages (August 2003)
Carmine Zoccali, Francesca Mallamaci  Kidney International 
The course of the remnant kidney model in mice
Organ transplantation goes to the movies
Volume 67, Pages S3-S9 (January 2005)
Volume 68, Issue 2, Pages (August 2005)
Volume 68, Issue 5, Pages (November 2005)
Volume 80, Issue 10, Pages (November 2011)
Is it the low-protein diet or simply the salt restriction?
Volume 64, Issue 4, Pages (October 2003)
Is complement a target for therapy in renal disease?
Volume 67, Issue 5, Pages (May 2005)
Sandrine Billet, Fréderick Aguilar, Camille Baudry, Eric Clauser 
Does an apple a day put hypertension in play?
Volume 66, Issue 2, Pages (August 2004)
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications 
Volume 66, Issue 4, Pages (October 2004)
T cells and T-cell receptors in acute renal failure
Volume 57, Issue 2, Pages (October 2000)
Volume 61, Issue 4, Pages (April 2002)
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men  J.A. Krikken, A.T. Lely, S.J.L. Bakker,
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Volume 63, Issue 2, Pages 617-623 (February 2003) Effects of angiotensin II receptor antagonism on the renal hemodynamic response to cardiovascular stress  Helga Frank, Hans-Paul Schobel, Jan Vitkowsky, Roland E. Schmieder, Karsten Heusser  Kidney International  Volume 63, Issue 2, Pages 617-623 (February 2003) DOI: 10.1046/j.1523-1755.2003.00760.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Experimental device for the lower body negative pressure (LBNP) test. Kidney International 2003 63, 617-623DOI: (10.1046/j.1523-1755.2003.00760.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Effects of angiotensin II type 1 receptor antagonist (AT1RA) with placebo (□) and eprosartan () on the renal hemodynamic response to LBNP. Kidney International 2003 63, 617-623DOI: (10.1046/j.1523-1755.2003.00760.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Effects of AT1RA on angiotensin II release with eprosartan and LBNP. Abbreviations are: NT, normotension; HT, mild hypertensives; E, eprosartan; Ang II, angiotensin II levels (ng/L). Kidney International 2003 63, 617-623DOI: (10.1046/j.1523-1755.2003.00760.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.